AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses.
Gillissen MA, Kedde M, Jong G, Moiset G, Yasuda E, Levie SE, Bakker AQ, Claassen YB, Wagner K, Böhne M, Hensbergen PJ, Speijer D, van Helden PM, Beaumont T, Spits H, Hazenberg MD.
Gillissen MA, et al. Among authors: beaumont t.
Blood. 2018 Jan 4;131(1):131-143. doi: 10.1182/blood-2017-02-768762. Epub 2017 Oct 23.
Blood. 2018.
PMID: 29061569
Free article.